Management

With over 25 years of leadership experience in life sciences and healthcare, Mika is an expert in healthcare data management, with a focus on data completeness and universality. He has a proven track record of bringing transformative technologies to market, driving growth, and fostering innovation.

Glenn Kramer has developed AI-enhanced computational geometry engines, transaction processing systems, business intelligence / market monitoring systems, and innovative investment products that use predictive analytics. He holds 22 issued US Patents. He was most recently Chief Data Scientist at SRS Acquiom. He holds BS and MS degrees in Electrical Engineering and Computer Science from MIT, and a PhD in Artificial Intelligence from the University of Sussex.

Mark Shapiro is a pharmacologist and widely recognized expert on growth and innovation strategies in clinical research and clinical development. As a management consultant at Campbell Alliance, he led strategic planning, growth, and change management initiatives at many pharmaceutical, biotech and clinical research organizations. He was most recently the SVP, Operations at Clinipace, a global, oncology-focused CRO, where he was part of the leadership team that grew the organization from ten to over a thousand employees worldwide.

Kenny has over a decade of product leadership/management experience in growing innovative healthcare products. Most recently, he was the Vice President of Products at GenomeSmart which was acquired by Ambry Genetics in 2020, a subsidiary of Konica Minolta. Prior to that, he was the Senior Product Director for Counsyl, which was acquired by Myriad Genetics in 2018. Kenny developed his passion for helping patients early in his career as a board-certified genetic counselor at UCSF Medical Center. He holds a BSc from University of British Columbia in Cell Biology and Genetics and a MS in Human Genetics from Sarah Lawrence College.